Dr. Stefan Schonland

Medical Degrees

• Studies in Human Medicine (Graduation) — University of Würzburg, Germany, completed 1990
• Doctorate (Dr. med.) — University of Würzburg, Germany
• Habilitation (Venia Legendi) — Ruprecht-Karls University of Heidelberg, Germany
• Professor (Univ.-Prof.) — Heidelberg University, Medical Faculty

Fellowships & Special Training

• Internship — Department of Hematology, Oncology & Rheumatology, Ruprecht-Karls University Heidelberg
• Research Fellowship — Department of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA (Laboratory of Prof. C.M. Weyand and Prof. J.J. Goronzy)
• Continuing professional development in systemic amyloidosis, multiple myeloma and stem-cell transplantation

Certifications & Accreditations

• Board Certification in Internal Medicine — Germany
• Board Certification in Hematology and Oncology — Germany
• Baden-Württemberg State Medical Council — Registered Specialist
• President — German Society of Amyloid Diseases (DGAK)
• President-Elect — International Society of Amyloidosis (ISA)

Current Affiliation

• Senior Physician (Oberarzt), Department of Internal Medicine V — Hematology / Oncology, Heidelberg University Hospital (UKHD), Im Neuenheimer Feld 410, 69120 Heidelberg (Present)
• Co-Founder & Co-Lead — Amyloidosis Center Heidelberg, UKHD (Present)
• Task Force Leader — Amyloidosis, Medical Clinic V, UKHD (Present)
• Professor of Medicine — Heidelberg University, Medical Faculty (Present)

Past Affiliations

• Mayo Clinic, Rochester, Minnesota, USA — Research Fellow, Department of Rheumatology (Lab of Prof. C.M. Weyand and Prof. J.J. Goronzy)
• Ruprecht-Karls University Heidelberg — Internship in Hematology, Oncology & Rheumatology
• University of Würzburg, Germany — Medical Studies and Doctorate, completed 1990

Academic & Research Roles

• Univ.-Prof. of Medicine — Medical Faculty Heidelberg
• President — German Society of Amyloid Diseases (DGAK)
• President-Elect — International Society of Amyloidosis (ISA)
• Active speaker at international amyloidosis, hematology and myeloma congresses (ASH, EHA, ISA, IMS)
• Active mentor for clinician-scientists and PhD candidates at UKHD

Key Achievements

• Co-Founder of the Amyloidosis Center Heidelberg — one of Europe’s leading amyloidosis referral centres
• President of the German Society of Amyloid Diseases (DGAK)
• President-Elect of the International Society of Amyloidosis (ISA)
• Multiple high-impact peer-reviewed publications on AL amyloidosis prognosis, staging and treatment
• Senior author / co-investigator of the multicentre HOVON 104 trial on bortezomib-based induction followed by stem-cell transplantation in light-chain amyloidosis